Redox vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
Redox processes 20M+ healthcare transactions/day and connects 75% of US health systems; strategic alliance with Kno2 in Oct 2025 creates a combined network transacting 40B+ annual transactions across 160,000 provider organizations.
About
Redox is a cloud-based healthcare data exchange and interoperability platform that enables digital health companies, health tech vendors, and healthcare organizations to connect and exchange clinical data across disparate EHR systems. Founded in 2014 and headquartered in Madison, Wisconsin, Redox standardizes healthcare data — translating between HL7 v2, FHIR, and proprietary EHR formats — and provides a single API integration layer that eliminates the need for vendors to build and maintain custom integrations with each health system they serve. The platform processes over 20 million transactions per day.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies;
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.